Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes - Fehse, F; Trautmann, M; Holst, J J; Halseth, A E; Nanayakkara, N; Nielsen, L L; Fineman, M S; Kim, D D; Nauck, M A (J Clin Endocrinol Metab, 2005)